700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
|Dr. Farid Menaa|
Department of Pharmaceutical Sciences
Dr. Farid Menaa is an experienced and renowned international scientist with interdisciplinary and multidisciplinary knowledge and a medical holistic point of view. He is the head of the oncology, stem cells, genomics and nanomedicine Department, Fluorotronics USA, Inc. and Global Innovation & Trade, Inc., San Diego, CA, USA. Dr. Menaa also collaborates as a project coordinator and R&D consultant for several worldwide institutions including universities, biotechnology, chemical, nanotechnological and pharmaceutical companies. He is often invited as a keynote or featured speaker and session chairman in various scientific, medical, technological and business events. Dr. Menaa earned a BSc in Biomedicine and Biochemistry, a BSc in Cell Biology and Physiology, a Master in Genetics, a National Master in Gerontology, a Doctorate in Radiation oncology and Gerontology, all with honors from prestigious French Universities. Dr. Menaa has also been trained in medicine, pharmacology and pharmaceutical sciences, chemistry/biochemistry, biophysics, genomics, immunology, nutrition, phytomedicine, biostatistics, bioinformatics, nanotechnology and business (Executive MBA). Dr. Menaa pursued his post-doctoral formation as principal investigator in Oncology (La Jolla, CA, USA), Dermatology (Wuerzburg, Germany) and in Hematology (São Paulo, Brazil). Dr. Menaa has organized and attended hundreds of scientific events (> 200), delivered lectures to many private organizations and academic institutions (>30), and further serves the scientific and medical communities as editor and reviewer for many esteemed journals (>60). Dr. Menaa is the recipient of several awards (>10), a member of prestigious scientific and medical associations (>10) and has published dozens of articles as first-author and/or corresponding author, including in the pharmaceutical sciences field.
Dr. Menaa´s R&D interests include the integration of innovative green techniques, state-of-the art technologies, methods and applications for personalized and translational medicine, in particular to improve the outcomes of cancer patients, stroke patients, and infected individuals as well as to delay the aging process. In the pharmaceutical fied, Dr. Menaa is interested in the drugs and natural compounds characterization, the design and development of new formulations. Dr. Menaa co-pioneered the development of a disruptive, green, non-invasive and versatile technology called Spectro-Fluor™ for pharmaceutical and biomedical applications.
Global Speakers in the subject
Global Experts in the subject